NCT01222533 - Tiotropium Respimat Pharmacokinetic Study in COPD | Biotech Hunter

Enrollment

154

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

November 30, 2011

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Tiotropium medium

Tiotropium inhalation solution medium dose

DRUG

Tiotropium low

Tiotropium inhalation solution low dose

DRUG

Tiotropium high

Tiotropium inhalation solution high dose

DRUG

Tiotropium 18mcg

Tiotropium inhalation powder 18mcg

DRUG

Tiotropium placebo

Placebo inhalation solution

Trial Locations (11)

205.458.32003 Boehringer Ingelheim Investigational Site, Genk

205.458.32001 Boehringer Ingelheim Investigational Site, Ghent

205.458.32002 Boehringer Ingelheim Investigational Site, Hasselt

205.458.45001 Boehringer Ingelheim Investigational Site, Copenhagen K

205.458.45003 Boehringer Ingelheim Investigational Site, København NV

205.458.45002 Boehringer Ingelheim Investigational Site, Odense C

205.458.35801 Boehringer Ingelheim Investigational Site, Helsinki

205.458.35802 Boehringer Ingelheim Investigational Site, Tampere

205.458.49001 Boehringer Ingelheim Investigational Site, Hanover

205.458.31001 Atrium Medisch Centrum Parkstad, Heerlen

205.458.31002 Ommelander ziekenhuis groep, locatie Lucas, Winschoten